Washington DC: Recent analysts have developed a pioneering technique to detect differences between immune cells in tumors that could accelerate the development of cancer treatments.
Researchers at the University of Edinburgh have analyzed genes from anonymized medical databases of thousands of tumors to identify genes associated with immune cells. The results of the study were published in the Journal of Cancer Immunology Research.
Researchers have found that this approach can help physicians choose the best treatments for individual patients and predict which cancers will respond to a particular treatment.
It can also help to focus on the use of immunotherapy – a new form of treatment that uses its own defense mechanisms in the fight against cancer. This therapy has been very promising in recent years, but determining which patients respond best is a challenge for doctors.
The new approach – based on gene analysis – makes it easier to detect the range of immune cells present in the tumor. These cells can help the body detect and kill cancer when they are activated by certain drugs, the researchers say.
Traditional methods of treatment, such as radiology, do not discriminate between cell types and attack both cancerous and healthy cells, often leading to side effects.
The source named ImSig – currently represents the best cancer and will allow scientists to investigate how certain types of immune cells affect the growth of cancer.